AlloDerm RTU® and AlloMaxTM are two acellular dermal matrices (ADMs) used in implant based breast reconstruction. In this study, we examined whether different processing methods for the ADMs lead to a disparity in histologic, clinical, and financial outcomes after breast reconstruction. Thirty patients were randomized into AlloMax or AlloDerm arms (n=15, each). ADM was placed at the time of immediate reconstruction. Patients were evaluated for complications on post-operative days 7, 14, and 30. During implant exchange, ADM biopsies were taken and compared histologically for vascular and cellular infiltration.
http://ift.tt/2lQ8YQ4
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου